Rationale and design of the national benchmarking and evidence-based national clinical guidelines for chronic heart failure management programs study Driscoll, Andrea, Worrall-Carter, Linda and Stewart, Simon 2006, Rationale and design of the national benchmarking and evidence-based national clinical guidelines for chronic heart failure management programs study, Journal of cardiovascular nursing, vol. 21, no. 4, pp. 276-282. Attached Files Name Description MIMEType Size Downloads Title Rationale and design of the national benchmarking and evidence-based national clinical guidelines for chronic heart failure management programs study Author(s) Driscoll, Andrea orcid.org/0000-0002-6837-0249 Worrall-Carter, Linda Stewart, Simon Journal name Journal of cardiovascular nursing Volume number 21 Issue number 4 Start page 276 End page 282 Publisher Lippincott Williams & Wilkins Place of publication Gaithersburg, Md. Publication date 2006-07 ISSN 0889-4655 Keyword(s) benchmarks chronic disease management programs chronic heart failure clinical audit postdischarge programs Summary OBJECTIVES: The National Benchmarks and Evidence-Based National Clinical Guidelines for Heart Failure Management Programs Study is a national, multicenter study designed to determine the nature, range, and effect of interventions applied by chronic heart failure management programs (CHF-MPs) throughout Australia on patient outcomes. Its primary objective is to use these data to develop national benchmarks and evidence-based clinical guidelines and optimize their cost-effective application by reducing quality and outcome variability. DATA SOURCES/STUDY SETTING: Primary data will be collected from CHF-MP coordinators and CHF patients enrolled in these programs on a national basis. Secondary outcome data will be collected from a national morbidity record and from patients' medical records. STUDY DESIGN: Stage I of the study involves a prospective clinical audit of all CHF-MPs throughout Australia (n = 45) to determine the extent of variability in programs currently. Stage II is a prospective cross-sectional survey design enrolling 1,500 patients (average of 40 patients per program) to firstly determine the typical profile of patients being managed via a CHF-MP in Australia and, secondly, the subsequent morbidity and mortality during the 6-month follow-up. Outcome data will be subject to multivariate analysis to determine the key components of care in this regard. All study data will be then examined in the final stage of the study (III) to develop national benchmarks for the application and auditing of CHF-MPs in Australia. CONCLUSION: Variability in patient outcomes is a product of heterogeneity among CHF-MPs. The development of national benchmarks will minimize such heterogeneity and will provide a greater level of evidence for their cost-effective application. Language eng Field of Research 110201 Cardiology (incl Cardiovascular Diseases) Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences HERDC Research category C1 Refereed article in a scholarly journal Copyright notice ©2006, Lippincott Williams & Wilkins Persistent URL http://hdl.handle.net/10536/DRO/DU:30003971 Document type: Journal Article Collections: Faculty of Health School of Nursing and Midwifery Centre for Quality and Patient Safety Research Related Links Link Description Connected to published version (restricted access) Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Versions Version Filter Type Tue, 04 Jun 2013, 11:14:20 EST Mon, 23 Sep 2013, 11:15:30 EST Fri, 10 Oct 2014, 08:17:07 EST Filtered Full Citation counts:   Cited 15 times in TR Web of Science Cited 17 times in Scopus Search Google Scholar Access Statistics: 944 Abstract Views, 0 File Downloads  -  Detailed Statistics Created: Mon, 07 Jul 2008, 09:08:27 EST